{
  "authors": [
    {
      "author": "Hurrem Bodur"
    },
    {
      "author": "Kursat Ozoran"
    },
    {
      "author": "Aylin Colpan"
    },
    {
      "author": "Neriman Balaban"
    },
    {
      "author": "Yalcin Tabak"
    },
    {
      "author": "Sezer Kulacoglu"
    }
  ],
  "doi": "10.1186/1476-0711-2-2",
  "publication_date": "2003-02-28",
  "id": "EN119794",
  "url": "https://pubmed.ncbi.nlm.nih.gov/12605719",
  "source": "Annals of clinical microbiology and antimicrobials",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A 17 years old male patient with arthritis and patellar osteomyelitis of the left knee whose further investigations revealed chronic granulomatous disease as the underlying disease is followed. Aspergillus fumigatus was isolated from the synovial fluid and the tissue samples cultures. He was treated with Amphotericin B deoxicolate 0.7 mg/kg/day. Also surgical debridement was performed our patient. Amphotericin B nephrotoxicity developed and the therapy switched to itraconazole 400 mg/day. Itraconazole therapy were discontinued at the 6th month. He can perform all the activities of daily living including."
}